Company Filing History:
Years Active: 2018
Title: Ana Ortega Molina: Innovator in Obesity Treatment
Introduction
Ana Ortega Molina is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medical research, particularly in the treatment of obesity and related conditions. Her innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Ana Ortega Molina holds a patent for the "Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and Ageing." This invention focuses on a phosphoinositide 3-kinase inhibitor that is utilized in the treatment or prevention of diseases associated with the expression of peroxisome proliferator-activated receptor gamma coactivator 1-α (Pgd1α) and uncoupling protein 1 (Thermogenin/Ucp1) in brown adipocytes. The patent highlights the potential for this treatment to address positive energy imbalance-associated conditions, such as obesity, steatosis, and biological aging. Additionally, it provides a method for promoting weight loss in individuals.
Career Highlights
Throughout her career, Ana has worked with esteemed institutions, including the Centro Nacional de Investigaciones Oncológicas (CNIO) and the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Ana has collaborated with notable professionals, including Manuel Serrano Marugan and Joaquin Pastor Fernández. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Ana Ortega Molina is a trailblazer in the field of obesity treatment, with her innovative patent paving the way for new therapeutic approaches. Her work exemplifies the impact of research and innovation on public health.